Article
Polymorphisms of the plasminogen activator inhibitor-1 gene in type 1 and type 2 diabetes, and in patients with diabetic retinopathy.
Thrombosis and haemostasis - 1 Jun 1994
Mansfield M W, Stickland M H, Carter A M, Grant P J
Abstract excerpt
To identify whether genotype contributes to the difference in PAI-1 levels in type 1 and type 2 diabetic subjects and whether genotype relates to the development of retinopathy, a Hind III restriction fragment length polymorphism and two dinucleotide repeat polymorphisms were studied. In 519 Caucasian diabetic subjects (192 type 1, 327 type 2) and 123 Caucasian control subjects there were no differences in the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.